期刊文献+

6-磷酸葡萄糖异构酶抗原检测在类风湿性关节炎中的诊断价值 被引量:2

Diagnostic Value of Glucose-6-phosphate Isomerase in Patients with Rheumatoid Arthritis
下载PDF
导出
摘要 目的检测类风湿性关节炎(RA)患者血清6-磷酸葡萄糖异构酶(GPI)抗原水平,探讨其在RA诊断中的价值。方法选取RA118例,非RA106例,正常对照组60例。对上述284份血清进行GPI抗原、CCP抗体及类风湿因子(IgM-RF)检测,分析GPI抗原水平与CCP抗体、IgM-RF的相关性。结果GPI抗原的阳性率在RA中为84.74%,非RA中为5.66%,正常人均为阴性。GPI抗原、CCP抗体及IgM-RF对RA诊断的敏感性和特异性分别为GPI84.74%、96.39%,CCP60.17%、95.18%,IgM-RF80.51%、79.52%。GPI抗原与CCP抗体在RA患者血清中阳性率的差异有显著性(P<0.01),与IgM-RF的差异无显著性(P>0.05)。相关分析显示3种方法的检测结果间存在相关性,两两联合检测可提高诊断效能。结论ELISA法检测血清GPI抗原简便、结果可靠,对RA诊断具有高灵敏度和特异性,可作为RA患者一个新的诊断指标。 Objective To detect glucose-6-phosphate isomerase (GPI) in patients with rheumatoid arthritis(RA) and explore its diagnostic value. Methods GPI,anti-CCP antibody and IgM-RF were detected in 284 serum samples ,118 from patients with established RA and 166 from non-RA controls. The correlations were analyzed among GPI,anti-CCP and IgM-RF. Results Among 118 patients with RA,106 patients showed positive GPI (84. 74%). Whereas, the positive percent was only 5.66%in 106 non-RA patients. The sensitivities and specificities of GPI,anti-CCP and IgM-RF were 84. 74% and 96.39%;60.17% and 95.18%; 80. 51% and 79.52% in RA respectively. The data showed that there was a significant difference between the results of GPI and anti-CCP assaying(P〈0. 01) by two methods. However,no difference was found between GPI and IgM-RF assaying(P〉0. 05). GPI was associated with anti-CCP and IgM-RF. The combination of the two assays could increase the diagnostic value. Conclusion Detecting GPI by ELISA may be a brief,standard and reliable method. It might present more sensitive and specific in clinical diagnosis on RA. GPI may be a useful parameter for the diagnostic work-up of rheumatoid arthritis.
出处 《临床输血与检验》 CAS 2008年第2期122-124,共3页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 6-磷酸葡萄糖异构酶 类风湿性关节炎 类风湿因子 Glucose-6-phosphateisomerase Rheumatoid arthritis Rheumatoid factor
  • 相关文献

参考文献6

  • 1Schaller M, Burton DR, Ditzel HJ. Autoantibodies to GPI in rheumatoid arthritis :linkage between an animal model and human disease [J]. Nat Immunol, 2001, 2 (8) : 746-753.
  • 2Kim JY,Lee MH,Jung KI,et al. Detection of anitibodies against glucose 6-phosphate isomerase in synovial fluid of rheumatoid arthritis using surface plasmon resonance[J]. Exp Mol Med, 2003,35(4) : 310-316.
  • 3Gurney ME, Heinrich SP, Lee MR, et al. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons [J]. Science, 1986,234 (4776) : 566-574.
  • 4Yu FL, Liao MH, Lee JW,et al. Induction of hepatoma cells migration by phosphate glucose isomerase autocrine motility factor through the upregulation of matrix metalloproteinase-3 [J]. Biochem Biophys Res Commun, 2004,314 (1) :76-82.
  • 5王晓霞,李小峰,王来远,胡学芳,张琳,李雪飞.类风湿关节炎血清基质金属蛋白酶-3水平及其影响因素的探讨[J].中华风湿病学杂志,2004,8(1):16-19. 被引量:31
  • 6卿之驹,贾凯,秦立新.葡萄糖6-磷酸异构酶在类风湿关节炎中的诊断意义[J].实用预防医学,2005,12(3):481-482. 被引量:43

二级参考文献21

  • 1Klimiuk PA,Sierakowski S,Latosiewicz R,et al.Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histologieal variants of rheumatoid synovitis. Rheumatology (Oxford),2002,41:78-87.
  • 2Yamanaka H,Matsuda Y,Tanaka M,et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement,in patients with early rheumatoid arthritis. Arthritis Rheum,2000,43:852-858.
  • 3Cunnane G,Fitz-Gerald O,Beeton C,et al. Early joint erosions and serum levels of matrix metalloproteinases 1,matrix metalloproteinases 3,and tissue inhibitor of metalloproteinases 1 in rheumatoid athritis.Arthritis Rheum,2001,44:2263 -2274.
  • 4Ishiguro N,Ito T,Obata K,et al. Determination of stromelysin-1,72 Kda type Ⅳ collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1),and TIMP-2 in synovial fluid and serum from patients with rheumatoidarthritis .J Rheumatol, 1996,23:1599-1604.
  • 5Wolfe F,Sharp JT.Radiographic outcome of recent-onset rheumatoid arthritis:a 19-year study of radiographic progression.Arthritis Rheum,1998,41:1571-1582.
  • 6Green MJ,Gough AK,Devlin J,et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology,2003,42:83-88.
  • 7Posthumus,MD,Limburg PC,Westra J. Serum matrix metalloproteinase 3in early rheumatoid arthritis is correlated with disease activity and radiological progression. J Rheumatol,2000,27:2761-2768.
  • 8Ribbens C,Andre B,Jaspar J.Matrix mettalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.J Rheumatol,2000,27:888-893.
  • 9Zucker S,Hymovitz M,Conner C,et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tis-sues:clinical experimental applications.Ann NY Acad Sci, 1999,878:212-227.
  • 10Okada Y.Proteinases and matrix degradation. In:Kelley WN,Ruddy S,Harris ED,eds.Textbook of rheumatology.6th ed. Philadelphia:WB Saunders,2000.55-72.

共引文献71

同被引文献10

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部